# Evaluation of the Effectiveness of Managing Chemotherapy Side Effects Using ePRO and a Standardized Telenursing Program for Cancer Patients

> **NCT07405931** · NA · RECRUITING · sponsor: **Ulsan University Hospital** · enrollment: 414 (estimated)

## Conditions studied

- Early Gastric Cancer
- Advanced Gastric Cancer
- Early Lung Cancer
- Advanced Lung Cancer
- Early Breast Cancer
- Advanced Breast Cancer
- Early Colon Cancer
- Advanced Colon Cancer

## Interventions

- **OTHER:** Standardized Telenursing
- **OTHER:** Smart Cancer Care Plus

## Key facts

- **NCT ID:** NCT07405931
- **Lead sponsor:** Ulsan University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-09
- **Primary completion:** 2026-03
- **Final completion:** 2026-09
- **Target enrollment:** 414 (ESTIMATED)
- **Last updated:** 2026-02-12

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07405931

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07405931, "Evaluation of the Effectiveness of Managing Chemotherapy Side Effects Using ePRO and a Standardized Telenursing Program for Cancer Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07405931. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*